APPARATUS AND METHOD FOR DISEASE DETECTION

• US 20020172936A1
• Filed: 11/08/1999
• Published: 11/21/2002
• Est. Priority Date: 03/27/1998
• Status: Abandoned Application

• Current Assignee: Seroptix Inc.
• Original Assignee: Seroptix Inc.
• Inventors: YANG, YONGWU, SAPIRSTEIN, VICTOR S., GREENWALD, MICHAEL A., EHRLICH, MELVIN P., ZHOU, WANGLONG, HARRISON, JAMES S., CANTER, JOSEPH M., KATSMAN, EUGENE, KOUL, OMANAND, LU, MICHAEL Y.
• Application Number:
  US09/436,207
• Publication Number:
  US 20020172936A1
• Time in Patent Office: Days
• US Class Current: 435/5
• CPC Class Codes: G01N 2021/6423 Spectral mapping, video display
• CPC Class Codes: G01N 21/31 Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry G01N21/72 takes precedence
• CPC Class Codes: G01N 21/6486 Measuring fluorescence of biological material, e.g. DNA, RNA, cells G01N21/6428 takes precedence

Abstract

The present invention relates to an apparatus and method for disease detection. The apparatus and method use a radiation source to irradiate a sample. An analyzer measures the absorption and/or emission spectra from the sample to detect the presence of the disease state in the sample. In this regard, a comparator may compare the measured spectra with the spectrum of a control. Analysis of the parameters of the spectra including, but not limited to, peak intensity wavelength, amplitude at the peak intensity, area ratio of left and right portions of the emission spectra, and shifts of the peak intensity wavelength, allows determination of HIV infection, Hepatitis A, B and C, and other diseases. Selective absorbents, such as C-M Affi Gel Blue and activated charcoal, may be used to treat the samples before measurements, which is found to improve discrimination of diseased and non-diseased samples. The present invention is capable of detecting HIV infection at a stage when it is still undetectable by conventional diagnosis methods.

Claims

1. A method for detecting presence of a diseased state, comprising:

a. obtaining a specimen;

b. preparing a sample from the specimen;

c. irradiating the sample;

d. obtaining at least one of absorption and emission spectra from the irradiated sample; and

e. analyzing the at least one of the absorption and emission spectra to determine the presence of the diseased state.

2. A method for detecting presence of an infection, comprising:

a. obtaining a specimen;

b. preparing a sample from the specimen;

c. irradiating the sample;

d. obtaining at least one of absorption and emission spectra from the irradiated sample; and

e. analyzing the at least one of the absorption and emission spectra to determine the presence of the infection.

3. A method for detecting presence of an infection, comprising:

a. obtaining a specimen;

b. preparing a sample from the specimen;

c. irradiating the sample;

d. obtaining at least one of absorption and emission spectra from the irradiated sample; and

e. analyzing the at least one of absorption and emission spectra to determine variation of the at least one of the absorption and emission spectra from a spectrum characteristic of a non-infected state to detect the presence of the infection.

4. A method comprising:

a. preparing a sample from an organism;

b. irradiating the sample;

c. obtaining at least one of absorption and emission spectra from the irradiated sample; and

d. analyzing the at least one of the absorption and emission spectra to determine the state of health of the organism.

5. An apparatus for detecting presence of a diseased state in a sample, comprising:

a. radiation source; and

b. analyzer operatively associated with the sample for measuring at least one of absorption and emission spectra from the sample to detect the presence of the diseased state in the sample.

6. The apparatus of claim 5 wherein the analyzer comprises a comparator to compare the at least one absorption and emission spectra with a signal characteristic of a non-diseased state.

7. The apparatus of claim 6 further comprising a memory unit coupled with the comparator and containing a plurality of pre-determined signals characteristic of non-diseased states.

8. The apparatus of claim 5 further comprising a sample holder disposed relative to the radiation source so that at least a portion of the sample can be irradiated.

9. The apparatus of claim 8 wherein the sample holder is a flow-through cell.

10. The apparatus of claim 5 wherein the radiation source emits electromagnetic radiation between about 270 and 400 nanometers.

11. The apparatus of claim 10 wherein the radiation source is a laser.

12. The apparatus of claim 10 wherein the radiation source comprises a filtered light source.

13. The apparatus of claim 5 wherein the analyzer comprises a spectrometer.

14. The apparatus of claim 13 wherein the spectrometer is a time-resolved spectrometer.

15. The apparatus of claim 13 wherein the spectrometer includes a polarizer.

16. The apparatus of claim 5 wherein the sample is one of plasma, serum, blood articles, and blood.

17. The apparatus of claim 5 wherein the sample is treated with an absorbent.

18. The apparatus of claim 17 wherein the absorbent is C-M Affi Gel Blue.

19. The apparatus of claim 17 wherein the absorbent is activated charcoal.

20. The apparatus of claim 5 wherein the analyzer measures at least one of a wavelength of maximum amplitude, a maximum intensity of the wavelength of maximum amplitude, and a predetermined area ratio of the at least one of absorption and emission spectra from the sample.

21. The apparatus of claim 5 wherein the diseased state is HIV.

22. The apparatus of claim 5 wherein the diseased state is hepatitis.

23. The apparatus of claim 5 wherein the analyzer measures the emission spectrum.

24. An apparatus for detecting presence of a diseased state, comprising:

a. means for irradiating the sample;

b. means for obtaining at least one of absorption and emission spectra from the irradiated sample; and

c. means for analyzing the at least one of the absorption and emission spectra to determine the presence of the diseased state.